Artwork
iconShare
 
Manage episode 523927916 series 3678700
Content provided by SueWallSt. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by SueWallSt or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Skye Bioscience $SKYE promised a breakthrough obesity drug—but when human trial results dropped, it didn’t even outperform a placebo. The stock plunged 60% in one day, and now executives are accused of cashing out while pumping up investor expectations. This episode of Sue Wall Street breaks down the lawsuit, the science spin, and what it means for biotech investors, traders, and anyone chasing the next pharma moonshot.

Visit ZLK.com for more info.

Add our WhatsApp Channel.

We’re not lawyers or accountants, so don’t take this as legal or financial advice.

  continue reading

76 episodes